Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells
Claude Gimmi(Dana-Farber Cancer Institute), Lee M. Nadler(Dana-Farber Cancer Institute), Jianlin Gong(Harvard University), Donald Küfe(Dana-Farber Cancer Institute), John G. Gribben(Queen Mary University of London), Daniel F. Hayes(University of Michigan–Ann Arbor), Gordon J. Freeman(Dana-Farber Cancer Institute), Briggs Morrison(Harvard University), Suun Young Lee Park(Harvard University), B. Mainprice(Harvard University), Michiaki Watanabe(Harvard University), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center)
Cited by 164
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k